Klinischer Nutzen intraläsionaler Methotrexat-Infiltration zur Unterscheidung kraterförmiger keratinozytärer Tumoren vor chirurgischem Eingriff.

JDDG: Journal der Deutschen Dermatologischen GesellschaftVolume 20, Issue 1 p. 102-105 Clinical LetterOpen Access Klinischer Nutzen intraläsionaler Methotrexat-Infiltration zur Unterscheidung kraterförmiger keratinozytärer Tumoren vor chirurgischem Eingriff Rafael Salido-Vallejo, Corresponding Author Rafael Salido-Vallejo [email protected] Department of Dermatology, University Clinic of Navarra, School of Medicine, University of Navarra, Pamplona, Spanien Department of Dermatology, Reina Sofía University Hospital, Córdoba, Spanien Korrespondenzanschrift Rafael Salido-Vallejo, MD, PhD Department of Dermatology University Clinic of Navarra, School of Medicine University of Navarra Avda. Pio XII, 36 31008 Pamplona, Spanien E-Mail: [email protected]Search for more papers by this authorJuan Luis Sanz-Cabanillas, Juan Luis Sanz-Cabanillas Department of Dermatology, Reina Sofía University Hospital, Córdoba, SpanienSearch for more papers by this authorJorge María Núñez-Córdoba, Jorge María Núñez-Córdoba Research Support Service, Central Clinical Trials Unit, University Clinic of Navarra, Pamplona, SpanienSearch for more papers by this authorAlberto González-Menchen, Alberto González-Menchen Department of Pathology, Reina Sofía University Hospital, Córdoba, SpanienSearch for more papers by this authorAntonio Vélez, Antonio Vélez Department of Dermatology, Reina Sofía University Hospital, Córdoba, SpanienSearch for more papers by this authorPedro Redondo, Pedro Redondo Department of Dermatology, University Clinic of Navarra, School of Medicine, University of Navarra, Pamplona, SpanienSearch for more papers by this author Rafael Salido-Vallejo, Corresponding Author Rafael Salido-Vallejo [email protected] Department of Dermatology, University Clinic of Navarra, School of Medicine, University of Navarra, Pamplona, Spanien Department of Dermatology, Reina Sofía University Hospital, Córdoba, Spanien Korrespondenzanschrift Rafael Salido-Vallejo, MD, PhD Department of Dermatology University Clinic of Navarra, School of Medicine University of Navarra Avda. Pio XII, 36 31008 Pamplona, Spanien E-Mail: [email protected]Search for more papers by this authorJuan Luis Sanz-Cabanillas, Juan Luis Sanz-Cabanillas Department of Dermatology, Reina Sofía University Hospital, Córdoba, SpanienSearch for more papers by this authorJorge María Núñez-Córdoba, Jorge María Núñez-Córdoba Research Support Service, Central Clinical Trials Unit, University Clinic of Navarra, Pamplona, SpanienSearch for more papers by this authorAlberto González-Menchen, Alberto González-Menchen Department of Pathology, Reina Sofía University Hospital, Córdoba, SpanienSearch for more papers by this authorAntonio Vélez, Antonio Vélez Department of Dermatology, Reina Sofía University Hospital, Córdoba, SpanienSearch for more papers by this authorPedro Redondo, Pedro Redondo Department of Dermatology, University Clinic of Navarra, School of Medicine, University of Navarra, Pamplona, SpanienSearch for more papers by this author First published: 18 January 2022 https://doi.org/10.1111/ddg.14637_gAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Volume20, Issue1January 2022Pages 102-105 RelatedInformation